Immunotherapy for advanced or metastatic urothelial carcinoma

Philipp Maisch; Eu Chang Hwang; Vikram Narayan; Caitlin J. Bakker; Frank Kunath; Philipp Dahm

doi:10.1002/14651858.CD013774

Immunotherapy for advanced or metastatic urothelial carcinoma

Philipp Maisch, Eu Chang Hwang, Vikram Narayan, Caitlin J. Bakker, Frank Kunath, Philipp Dahm

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

Original language	English (US)
Article number	CD013774
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	11
DOIs	https://doi.org/10.1002/14651858.CD013774
State	Published - 2020

Bibliographical note

Funding Information:
We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol.

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1002/14651858.CD013774

Find It

Find It at U of M Libraries

Cite this

@article{d7fe65f313c4458abd1d401f3398571d,

title = "Immunotherapy for advanced or metastatic urothelial carcinoma",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.",

author = "Philipp Maisch and Hwang, {Eu Chang} and Vikram Narayan and Bakker, {Caitlin J.} and Frank Kunath and Philipp Dahm",

note = "Funding Information: We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol. Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

doi = "10.1002/14651858.CD013774",

language = "English (US)",

volume = "2020",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Immunotherapy for advanced or metastatic urothelial carcinoma

AU - Maisch, Philipp

AU - Hwang, Eu Chang

AU - Narayan, Vikram

AU - Bakker, Caitlin J.

AU - Kunath, Frank

AU - Dahm, Philipp

N1 - Funding Information: We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol. Publisher Copyright: Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020

Y1 - 2020

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85103050341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103050341&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013774

DO - 10.1002/14651858.CD013774

M3 - Article

AN - SCOPUS:85103050341

SN - 1465-1858

VL - 2020

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD013774

ER -

Immunotherapy for advanced or metastatic urothelial carcinoma

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this